In summary, compared to insulin resistance, insulin sensitivity can be described as lower insulin secretion but efficient insulin signaling and better glycemic control, However, our in vivo and in vitro results collectively uncovered an interesting paradigm where proximal insulin signaling is impaired, yet insulin secretion is reduced and glucose disposal is enhanced. The gene discussed is INS; the disease is Insulin resistance.